113 related articles for article (PubMed ID: 830927)
1. Pancreatic extracts in the management of cystic fibrosis.
Finberg L
J Pediatr; 1977 Feb; 90(2):306. PubMed ID: 830927
[No Abstract] [Full Text] [Related]
2. Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis.
Stapleton FB; Kennedy J; Nousia-Arvanitakis S; Linshaw MA
N Engl J Med; 1976 Jul; 295(5):246-8. PubMed ID: 934188
[TBL] [Abstract][Full Text] [Related]
3. Allergy in cystic fibrosis nurses to pancreatic extract.
Lipkin GW; Vickers DW
Lancet; 1987 Feb; 1(8529):392. PubMed ID: 2880202
[No Abstract] [Full Text] [Related]
4. Extensive pathological changes of the colon in cystic fibrosis and high-strength pancreatic enzymes.
Knabe N; Zak M; Hansen A; Moesgaard J; Kvist N; Beck B; Damgaard K; Koch C
Lancet; 1994 May; 343(8907):1230. PubMed ID: 7909898
[No Abstract] [Full Text] [Related]
5. Therapeutic approach to pancreatic extract-induced hyperuricosuria in cystic fibrosis.
Nouisa-Arvanitakis S; Stapleton FB; Linshaw MA; Kennedy J
J Pediatr; 1977 Feb; 90(2):302-5. PubMed ID: 830926
[TBL] [Abstract][Full Text] [Related]
6. Ulcerative type of colitis associated with the use of high strength pancreatic enzyme supplements in cystic fibrosis.
Ablin DS; Ziegler M
Pediatr Radiol; 1995; 25(2):113-5; discussion 115-6. PubMed ID: 7596655
[TBL] [Abstract][Full Text] [Related]
7. Hyperuricemia in cystic fibrosis.
J Pediatr; 1979 Aug; 95(2):330-1. PubMed ID: 448582
[No Abstract] [Full Text] [Related]
8. Pancreatic extracts.
Br Med J; 1970 Apr; 2(5702):161-3. PubMed ID: 5440600
[No Abstract] [Full Text] [Related]
9. Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy.
Pettei MJ; Leonidas JC; Levine JJ; Gorvoy JD
J Pediatr; 1994 Oct; 125(4):587-9. PubMed ID: 7931879
[TBL] [Abstract][Full Text] [Related]
10. Iatrogenic hyperuricemia in children with cystic fibrosis.
Davidson GP; Hassel FM; Crozier D; Corey M; Forstner GG
J Pediatr; 1978 Dec; 93(6):976-8. PubMed ID: 722445
[No Abstract] [Full Text] [Related]
11. Fibrosing colonopathy in children with cystic fibrosis.
Littlewood JM
Postgrad Med J; 1996 Mar; 72(845):129-30. PubMed ID: 8731700
[No Abstract] [Full Text] [Related]
12. [Pancreatic opotherapy in mucoviscidosis and in small secondary pancreatic insufficiency in infants].
Mastella G; Buffatti G
Minerva Pediatr; 1967 Jun; 19(22):1082-91. PubMed ID: 5610102
[No Abstract] [Full Text] [Related]
13. Pancreatic enzyme supplement dosage in cystic fibrosis.
Owen G; Peters TJ; Dawson S; Goodchild MC
Lancet; 1991 Nov; 338(8775):1153. PubMed ID: 1682579
[No Abstract] [Full Text] [Related]
14. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
FitzSimmons SC; Burkhart GA; Borowitz D; Grand RJ; Hammerstrom T; Durie PR; Lloyd-Still JD; Lowenfels AB
N Engl J Med; 1997 May; 336(18):1283-9. PubMed ID: 9113931
[TBL] [Abstract][Full Text] [Related]
15. [Diseases of the exocrine pancreas in infants and children. A review. 1. Organic pancreatic diseases].
Niessen KH
Fortschr Med; 1980 Feb; 98(8):263-8. PubMed ID: 6155320
[No Abstract] [Full Text] [Related]
16. High-strength pancreatic enzymes.
Innes JA; Greening AP; Webb K
Lancet; 1994 Mar; 343(8897):599. PubMed ID: 7906347
[No Abstract] [Full Text] [Related]
17. High-strength pancreatic enzymes.
Mahony MJ; Corcoran M
Lancet; 1994 Mar; 343(8897):599-600. PubMed ID: 7906349
[No Abstract] [Full Text] [Related]
18. Progressive pan-colonic fibrosis secondary to oral administration of pancreatic enzymes.
Moss RL; Musemeche CA; Feddersen RM
Pediatr Surg Int; 1998 Mar; 13(2-3):168-70. PubMed ID: 9563037
[TBL] [Abstract][Full Text] [Related]
19. Concern about records of fibrosing colonopathy study.
Dodge JA
Lancet; 2001 May; 357(9267):1526-7. PubMed ID: 11383534
[No Abstract] [Full Text] [Related]
20. High-strength pancreatic enzymes.
Milla CE; Wielinski CL; Warwick WJ
Lancet; 1994 Mar; 343(8897):599. PubMed ID: 7906348
[No Abstract] [Full Text] [Related]
[Next] [New Search]
